Ignite Creation Date:
2024-05-06 @ 5:56 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05484011
Status:
TERMINATED
Last Update Posted:
2024-04-10
First Post:
2022-07-15
Brief Title:
A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
HiberCell Inc
Organization:
HiberCell Inc
Organization Data
Organization:
HiberCell Inc
Class:
INDUSTRY
Study ID:
PGG-PAN2111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
HiberCell Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celldex Therapeutics | INDUSTRY |